Epidemiological parallels of community-acquired pneumonia, influenza and ARVI in Moscow
https://doi.org/10.21292/2075-1230-2020-98-3-6-12
Abstract
The problem of community-acquired pneumonia continues to be urgent due to high incidence, hospital admission rates, and mortality.
The objective of the study is to characterize epidemiological parameters of incidence and mortality of community-acquired pneumonia, influenza, and ARVI in Moscow.
Subjects and methods. The incidence and mortality of community-acquired pneumonia, influenza, and ARVI among different population groups in Moscow were analyzed. The Pearson correlation coefficient (rxy) was calculated to assess the relationship between incidence of pneumonia, influenza, and ARVI. Data were analyzed using IBM SPSS Statistics IBM statistics, version 23.0.
Results. Over the studied period of long-term changes in the incidence of community-acquired pneumonia among all population groups, a pronounced upward trend is observed. The highest incidence rates of community-acquired pneumonia in Moscow are registered among under in infants one year, 1-2 years old and 3-6 years old pediatric patients. The months of the maximum incidence of community-acquired pneumonia in adults coincide with the months of the maximum incidence of influenza (January - February). The maximum incidence of community-acquired pneumonia among children 15-17 years old and 0-14 years old is registered 2 months earlier than with influenza. The highest mortality of pneumonia is observed after 1-2 months after the maximum incidence of ARVI and influenza, which is due to delayed mortality as a result of the exacerbation of chronic diseases. The authors suggest considering simultaneous vaccinations against influenza and pneumococcal infection among people over 65 years old and high-risk groups during the pre-season vaccination against influenza.
About the Authors
T. S. Saltykova
I. M. Sechenov First Moscow State Medical University (Sechenov University); Central Research Institute of Epidemiology of the Federal Service on Customers' Rights Protection and Human Well-Being Surveillance
Russian Federation
Russian Federation
Tatiana S. Saltykova - Associate Professor of Epidemiology and Evidence-Based Medicine Department.
2, Bd. 2, Bolshaya Serpukhovskaya St., Moscow, 119991
B. A. Zhigarlovskiy
I. M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Bronislav A. Zhigarlovskiy - Post-Graduate Student of Epidemiology and Evidence-Based Medicine Department.
2 Bd. 2, Bolshaya Serpukhovskaya St., Moscow, 119991
N. I. Briko
I. M. Sechenov First Moscow State Medical University (Sechenov University); Central Research Institute of Epidemiology of the Federal Service on Customers' Rights Protection and Human Well-Being Surveillance
Russian Federation
Russian Federation
Nikolay I. Briko - Honored Scientist of RF, Academician of RAS, Professor, Chief Epidemiologist, Director.
2, Bd. 2, Bolshaya Serpukhovskaya St., Moscow, 119991
Yu. V. Vyazovichenko
I. M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Yury E. Vyazovichenko - Professor of Epidemiology and Evidence-Based Medicine Department
2, Bd. 2, Bolshaya Serpukhovskaya St., Moscow, 119991
References
1. Avdeev S.N. Pneumonia and acute respiratory distress syndrome caused by А (H1N1).Pulmonoloiya, 2010, no. 1, pp. 32-46. Annex: А (H1N1): lessons learned from pandemic. (In Russ.)
2. Baranova I.P., Malova ЕА., Fedoseeva N.V. Etiological structure of ARVI and influenza in the patients admitted to the in-patient unit on the territory with restricted access. Infektsionnye Bolezni, Prilozeniye, 2014, no. 12, pp. 28. (In Russ.)
3. Vnebolnichnaya pnevmoniya u detey: rasprostranennost, diagnostika, lechenie i profilaktika: nauchno-prakticheskaya programma. Rossiyskoe respiratornoe o-vo, Federatsiya pediatrov stran SNG, Moskovskoe o-vo detskikh vrachey. [Community-acquired pneumonia in children: prevalence, diagnostics, treatment and prevention: scientific and practical problem. Russian Respiratory Society, Federation of Pediatricians of CIS Countries, Moscow Society of Pediatricians]. Moscow, Original-maket, 2012, 63 p.
4. Govorin А/V. et al. Clinical features of community-acquired pneumonia in patients with influenza A/H1N1. Pulmonoloiya, 2010, no. 5, pp. 27-29. (In Russ.)
5. Kim S.S. et al. The role of viruses in community-acquired pneumonia in children. Voprosy Diagnostiki v Pediatrii, 2012, vol. 4, no. 4, pp. 21-25. (In Russ.)
6. Annex no. 1 to Edict no. 125n by the Russian MoH as of March 21, 2014. (In Russ.)
7. Annex no. 2 to Edict no. 125n by the Russian MoH as of March 21, 2014. (In Russ.)
8. Saltykova T.S. Zabolevaemost grippom i otsrochennaya smertnost lits starshe 60 let. Avtoref. diss. cand. med. nauk. [Influenza incidence and delayed mortality in those above 60 y.o. Synopsis of Cand. Diss.]. 14.02.02. Moscow, 2010. 23 p.
9. Smirnov А/V, Kirillova E.N., Аrkhipov G.S. Circulation of viruses of influenza and ARVI in Novgorod Region in 2005-2015. Vestn. Novg. Gos. Un-ta. Ser.: Meditsinskie Nauki, 2016, no. 1 (92), pp. 17-21. (In Russ.)
10. Somova А.М, Romanenko V.V., Golubkova А.А. Epidemiology of S. pneumoniae-associated pneumonias and analysis of efficacy of vaccination against pneumococcal diseases in children above 6 years old. Epidemiologiya i Vaktsionoprofilaktika, 2018, vol. 17, no. 1, pp. 25-32. (In Russ.)
11. Tatochenko V.K. Klinicheskie rekomendatsii. Pediatriya (pnevmoniya u detey). [Guidelines. Pediatrics (pneumonia in children)]. A.A. Baranov, eds., Moscow, GEOTAR-Media Publ., 2005, 28 p.
12. Khamitov R.F., Palmova L.Yu., Sulbaeva K.R. Cases of severe pneumonia in clinical practice. Kazanskiy Meditsinskiy Journal, 2016, vol. 97, no. 6, pp. 994-99. (In Russ.) doi: 10.17750/KMJ2016-994.
13. Chuchalin А^. Pneumonia: the topical medical issue in the XXIth century. Pulmonoloiya, 2015, vol. 25, no. 2, pp. 133-142. (In Russ.)
14. Bautista E. et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med., 2010, no. 362, pp. 1708-1719.
15. Cohen R. et al. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr. Infect. Dis. J., 2012, vol. 31, no. 3, pp. 297-301.
16. Dagan R. et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin. Infect. Dis., 2013, vol. 57, no. 7, pp. 952-962.
17. Grant L.R. et al. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage among American Indians. Pediatr. Infect. Dis. J., 2016, vol. 35, no. 8, pp. 907-914.
18. Ho Y.C. et al. Prognostic factors for fatal adult influenza pneumonia. J. Infect., 2009, no. 58, pp. 439-445.
19. Jain S. et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med., 2009, vol. 361, no. 20, pp. 1935-1944.
20. Marx J.A., Hockberger R.S., Walls R.M. Pneumonia. In Rosen's Emergency Medicine. 8. Philadelphia. Mosby Elsevier. 2013, pp. 978-987.
21. Rohde G. The role of viruses in CAP. European respiratory monograph 63: Community-acquired pneumonia. J. Chalmers, M. Pletz, S. Alib erti. 2014, pp. 74-87.
Review
For citations:
Saltykova T.S., Zhigarlovskiy B.A., Briko N.I., Vyazovichenko Yu.V. Epidemiological parallels of community-acquired pneumonia, influenza and ARVI in Moscow. Tuberculosis and Lung Diseases. 2020;98(3):6-12. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-3-6-12
Views:
1042
Email this article 